USA flag logo/image

An Official Website of the United States Government

PNA-Based Rapidly Adaptable Anti-Microbial Nanoparticles

Award Information

Agency:
Department of Defense
Branch:
Defense Advanced Research Projects Agency
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
D121-003-0051
Solicitation Year:
2012
Solicitation Topic Code:
SB121-003
Solicitation Number:
2012.1
Small Business Information
Agave BioSystems, Inc.
P.O. Box 100 Ithaca, NY -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: PNA-Based Rapidly Adaptable Anti-Microbial Nanoparticles
Agency / Branch: DOD / DARPA
Contract: W911QX-12-C-0074
Award Amount: $100,000.00
 

Abstract:

Agave BioSystems proposed to develop a system of Rapidly Adaptable Nanotherapeutics (RANT) by combining advanced bioformatics, with DNA-based nanoparticles, peptide nucleic acid (PNA) antisense oligonucleotides, and cell permeating peptides (CPPs). Advanced bioinformatics computing will allow for the identification of essential and drug resistance genes within the target pathogens. These genes will be used to develop and synthesize PNA based anti-sense oligonucleotides. These PNAs are designed to suppress the growth and destroy the target microorganisms. DNA nanoparticles coated with CPPs will be used to get the anti-sense PNAs into the target microorganisms. Combined, these components will allow for the rapid targeting of essential or drug resistance microbial genes, and the delivery of stable antisense oligonucleotides into the target microorganisms.

Principal Investigator:

Joel Tabb
Principal Scientist
(607) 272-0002
jtabb@agavebio.com

Business Contact:

Noe Salazar
President
(512) 656-6200
nsalazar@agavebio.com
Small Business Information at Submission:

Agave BioSystems, Inc.
P.O. Box 100 Ithaca, NY -

EIN/Tax ID: 161551819
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: Yes